Hereditary and non-hereditary branches of family eligible for BRCA test: Cancers in other sites

M. Digennaro, D. Sambiasi, S. Tommasi, B. Pilato, S. Diotaiuti, A. Kardhashi, G. Trojano, A. Tufaro, A. V. Paradiso

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: The analysis of relationships of BRCA alterations with cancer at sites other than breast/ovary may provide innovative information concerning BRCA pathogenic role and support additional clinical decisions. Aim of this study is to compare presence of cancers in other sites in members of hereditary (H) and not-hereditary (nH) branches of families of patients eligible to BRCA test. Methods: We retrospectively analyzed the incidence of cancer in other sites in members of 136 families eligible for hereditary breast/ovarian cancer genetic counseling at Centro Studi Tumori Eredo-familiari of our Institute; we compared the frequency of other cancer types in 1156 members of the H-branch with respect to 1062 members of nH-Branch. The families belonging to a proband case and with informative members in at least three generation entered the present study. Results: The frequency of other Cancers in members of H-branch was significantly higher than that in members of nH-branch (161 vs 75 cancers; p<0.0001). In specific, members of H-branch had a significantly higher probability to have more lung cancer (38 vs 9;p<0.0006), kidney cancer (23 vs 5;p<0.0005), liver cancer (13 vs 3;p<0.02) and larynx cancer (14 vs 4;p<0.03). Interestingly, to belong to H-branch resulted significantly associated with a higher probability of lung cancer (OR 4.5; 2.15-9.38 95%C.I.), liver cancer (OR: 4.02; 1.14-14.15 95% C.I.) and larynx cancer (OR:3.4; 1.12-10.39 95%C.I.) independently from Gender and Age. Conclusions: Members belonging to the H-branch of families of patients eligible to BRCA test have a higher risk of tumors in lung, larynx and liver. Clinicians should consider the increased risk for these cancers to activate prevention/early diagnosis practices in members of families with breast/ovarian familial cancer syndrome.

Original languageEnglish
Article number7
JournalHereditary Cancer in Clinical Practice
Volume15
Issue number1
DOIs
Publication statusPublished - May 25 2017

Fingerprint

Neoplasms
Laryngeal Neoplasms
Liver Neoplasms
Ovarian Neoplasms
Lung Neoplasms
Breast
Clinical Decision Support Systems
Kidney Neoplasms
Genetic Counseling
Larynx
Early Diagnosis
Ovary
Breast Neoplasms
Lung
Liver
Incidence

Keywords

  • Breast/ovarian cancer
  • Cancer in other sites
  • Hereditary syndrome
  • Hereditary/non hereditary branch

ASJC Scopus subject areas

  • Oncology
  • Genetics(clinical)

Cite this

Hereditary and non-hereditary branches of family eligible for BRCA test : Cancers in other sites. / Digennaro, M.; Sambiasi, D.; Tommasi, S.; Pilato, B.; Diotaiuti, S.; Kardhashi, A.; Trojano, G.; Tufaro, A.; Paradiso, A. V.

In: Hereditary Cancer in Clinical Practice, Vol. 15, No. 1, 7, 25.05.2017.

Research output: Contribution to journalArticle

@article{f13b39ad579d43bf848f249407f9f747,
title = "Hereditary and non-hereditary branches of family eligible for BRCA test: Cancers in other sites",
abstract = "Background: The analysis of relationships of BRCA alterations with cancer at sites other than breast/ovary may provide innovative information concerning BRCA pathogenic role and support additional clinical decisions. Aim of this study is to compare presence of cancers in other sites in members of hereditary (H) and not-hereditary (nH) branches of families of patients eligible to BRCA test. Methods: We retrospectively analyzed the incidence of cancer in other sites in members of 136 families eligible for hereditary breast/ovarian cancer genetic counseling at Centro Studi Tumori Eredo-familiari of our Institute; we compared the frequency of other cancer types in 1156 members of the H-branch with respect to 1062 members of nH-Branch. The families belonging to a proband case and with informative members in at least three generation entered the present study. Results: The frequency of other Cancers in members of H-branch was significantly higher than that in members of nH-branch (161 vs 75 cancers; p<0.0001). In specific, members of H-branch had a significantly higher probability to have more lung cancer (38 vs 9;p<0.0006), kidney cancer (23 vs 5;p<0.0005), liver cancer (13 vs 3;p<0.02) and larynx cancer (14 vs 4;p<0.03). Interestingly, to belong to H-branch resulted significantly associated with a higher probability of lung cancer (OR 4.5; 2.15-9.38 95{\%}C.I.), liver cancer (OR: 4.02; 1.14-14.15 95{\%} C.I.) and larynx cancer (OR:3.4; 1.12-10.39 95{\%}C.I.) independently from Gender and Age. Conclusions: Members belonging to the H-branch of families of patients eligible to BRCA test have a higher risk of tumors in lung, larynx and liver. Clinicians should consider the increased risk for these cancers to activate prevention/early diagnosis practices in members of families with breast/ovarian familial cancer syndrome.",
keywords = "Breast/ovarian cancer, Cancer in other sites, Hereditary syndrome, Hereditary/non hereditary branch",
author = "M. Digennaro and D. Sambiasi and S. Tommasi and B. Pilato and S. Diotaiuti and A. Kardhashi and G. Trojano and A. Tufaro and Paradiso, {A. V.}",
year = "2017",
month = "5",
day = "25",
doi = "10.1186/s13053-017-0067-8",
language = "English",
volume = "15",
journal = "Hereditary Cancer in Clinical Practice",
issn = "1731-2302",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Hereditary and non-hereditary branches of family eligible for BRCA test

T2 - Cancers in other sites

AU - Digennaro, M.

AU - Sambiasi, D.

AU - Tommasi, S.

AU - Pilato, B.

AU - Diotaiuti, S.

AU - Kardhashi, A.

AU - Trojano, G.

AU - Tufaro, A.

AU - Paradiso, A. V.

PY - 2017/5/25

Y1 - 2017/5/25

N2 - Background: The analysis of relationships of BRCA alterations with cancer at sites other than breast/ovary may provide innovative information concerning BRCA pathogenic role and support additional clinical decisions. Aim of this study is to compare presence of cancers in other sites in members of hereditary (H) and not-hereditary (nH) branches of families of patients eligible to BRCA test. Methods: We retrospectively analyzed the incidence of cancer in other sites in members of 136 families eligible for hereditary breast/ovarian cancer genetic counseling at Centro Studi Tumori Eredo-familiari of our Institute; we compared the frequency of other cancer types in 1156 members of the H-branch with respect to 1062 members of nH-Branch. The families belonging to a proband case and with informative members in at least three generation entered the present study. Results: The frequency of other Cancers in members of H-branch was significantly higher than that in members of nH-branch (161 vs 75 cancers; p<0.0001). In specific, members of H-branch had a significantly higher probability to have more lung cancer (38 vs 9;p<0.0006), kidney cancer (23 vs 5;p<0.0005), liver cancer (13 vs 3;p<0.02) and larynx cancer (14 vs 4;p<0.03). Interestingly, to belong to H-branch resulted significantly associated with a higher probability of lung cancer (OR 4.5; 2.15-9.38 95%C.I.), liver cancer (OR: 4.02; 1.14-14.15 95% C.I.) and larynx cancer (OR:3.4; 1.12-10.39 95%C.I.) independently from Gender and Age. Conclusions: Members belonging to the H-branch of families of patients eligible to BRCA test have a higher risk of tumors in lung, larynx and liver. Clinicians should consider the increased risk for these cancers to activate prevention/early diagnosis practices in members of families with breast/ovarian familial cancer syndrome.

AB - Background: The analysis of relationships of BRCA alterations with cancer at sites other than breast/ovary may provide innovative information concerning BRCA pathogenic role and support additional clinical decisions. Aim of this study is to compare presence of cancers in other sites in members of hereditary (H) and not-hereditary (nH) branches of families of patients eligible to BRCA test. Methods: We retrospectively analyzed the incidence of cancer in other sites in members of 136 families eligible for hereditary breast/ovarian cancer genetic counseling at Centro Studi Tumori Eredo-familiari of our Institute; we compared the frequency of other cancer types in 1156 members of the H-branch with respect to 1062 members of nH-Branch. The families belonging to a proband case and with informative members in at least three generation entered the present study. Results: The frequency of other Cancers in members of H-branch was significantly higher than that in members of nH-branch (161 vs 75 cancers; p<0.0001). In specific, members of H-branch had a significantly higher probability to have more lung cancer (38 vs 9;p<0.0006), kidney cancer (23 vs 5;p<0.0005), liver cancer (13 vs 3;p<0.02) and larynx cancer (14 vs 4;p<0.03). Interestingly, to belong to H-branch resulted significantly associated with a higher probability of lung cancer (OR 4.5; 2.15-9.38 95%C.I.), liver cancer (OR: 4.02; 1.14-14.15 95% C.I.) and larynx cancer (OR:3.4; 1.12-10.39 95%C.I.) independently from Gender and Age. Conclusions: Members belonging to the H-branch of families of patients eligible to BRCA test have a higher risk of tumors in lung, larynx and liver. Clinicians should consider the increased risk for these cancers to activate prevention/early diagnosis practices in members of families with breast/ovarian familial cancer syndrome.

KW - Breast/ovarian cancer

KW - Cancer in other sites

KW - Hereditary syndrome

KW - Hereditary/non hereditary branch

UR - http://www.scopus.com/inward/record.url?scp=85019686742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019686742&partnerID=8YFLogxK

U2 - 10.1186/s13053-017-0067-8

DO - 10.1186/s13053-017-0067-8

M3 - Article

AN - SCOPUS:85019686742

VL - 15

JO - Hereditary Cancer in Clinical Practice

JF - Hereditary Cancer in Clinical Practice

SN - 1731-2302

IS - 1

M1 - 7

ER -